Lynn E. Heasley
Affiliations: | University of Colorado Anschutz Medical Campus, Denver, Aurora, CO |
Area:
Cancer Biology, PharmacologyGoogle:
"Lynn Heasley"Parents
Sign in to add mentorVictor Heasley | research assistant | 1976-1980 | Point Loma Nazarene University | |
(Undergraduate Mentor) | ||||
Michael R. McConnell | research assistant | 1976-1980 | Point Loma Nazarene University | |
(undergraduate researcher) | ||||
Laurence L. Brunton | grad student | 1980-1985 | UCSD (Neurotree) | |
Gary L. Johnson | post-doc | 1985-1991 | University Of Massachusetts Med Sch Worcester/National Jewish Research Ctr (Chemistry Tree) |
Children
Sign in to add traineeSun-Young Han | grad student | 2000-2005 | University of Colorado, Denver |
Katherine E. Ware | grad student | 2008-2012 | University of Colorado, Denver |
Kathryn R. Singleton | grad student | 2009-2013 | University of Colorado, Denver |
Emily K. Kleczko | grad student | 2000-2015 | University of Colorado, Denver |
Collaborators
Sign in to add collaboratorRaphael A. Nemenoff | collaborator | 1991-2019 | University of Colorado, Denver |
Aik-choon Tan | collaborator | 2009-2019 | University of Colorado, Denver |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Schubert L, Le AT, Hinz TK, et al. (2023) A Functional sgRNA-CRISPR screening method for generating murine RET and NTRK1 rearranged oncogenes. Biology Open |
Schubert L, Le AT, Hinz TK, et al. (2023) A Rapid, Functional sgRNA Screening Method for Generating Murine RET and NTRK1 Fusion Oncogenes. Biorxiv : the Preprint Server For Biology |
Sisler DJ, Hinz TK, Le AT, et al. (2023) Evaluation of KRAS inhibitor responses in novel murine KRAS lung cancer cell line models. Frontiers in Oncology. 13: 1094123 |
Kleczko EK, Hinz TK, Nguyen TT, et al. (2023) Durable responses to alectinib in murine models of EML4-ALK lung cancer requires adaptive immunity. Npj Precision Oncology. 7: 15 |
Kleczko EK, Poczobutt JM, Navarro AC, et al. (2023) Upregulation of complement proteins in lung cancer cells mediates tumor progression. Frontiers in Oncology. 12: 1045690 |
Kleczko EK, Le AT, Hinz TK, et al. (2023) Novel EGFR-mutant mouse models of lung adenocarcinoma reveal adaptive immunity requirement for durable osimertinib response. Cancer Letters. 216062 |
Bhatia S, Nguyen D, Darragh LB, et al. (2022) EphB4 and ephrinB2 act in opposition in the head and neck tumor microenvironment. Nature Communications. 13: 3535 |
Johnson AM, Boland JM, Wrobel J, et al. (2021) Cancer cell-specific MHCII expression as a determinant of the immune infiltrate organization and function in the non-small cell lung cancer tumor microenvironment. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer |
Hinz TK, Kalkur R, Rabinovitch J, et al. (2021) . Molecular Pharmacology |
Gurule NJ, McCoach CE, Hinz TK, et al. (2021) A tyrosine kinase inhibitor-induced interferon response positively associates with clinical response in EGFR-mutant lung cancer. Npj Precision Oncology. 5: 41 |